Early vvECMO implantation may be associated with lower mortality in ARDS

BACKGROUND: Venovenous extracorporeal membrane oxygenation (vvECMO) is used to treat hypoxia in patients with severe acute respiratory distress syndrome (ARDS). Nevertheless, uncertainty exists regarding the optimal timing of initiation of vvECMO therapy. We aimed to investigate the association betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberger, Peter, Korell, Lisa, Haeberle, Helene A., Mirakaj, Valbona, Bernard, Alice, Tang, Linyan, Körner, Andreas, Martus, Peter, Koeppen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521539/
https://www.ncbi.nlm.nih.gov/pubmed/37752522
http://dx.doi.org/10.1186/s12931-023-02541-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521539/
https://www.ncbi.nlm.nih.gov/pubmed/37752522
http://dx.doi.org/10.1186/s12931-023-02541-z

Ejemplares similares